Literature DB >> 30734351

Clinicopathologic features, management, and outcomes of plasmablastic lymphoma: A 10-year experience.

Nivedita Arora1, Corbin Eule1, Arjun Gupta1, Hsiao C Li2,3, Navid Sadeghi2,3.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30734351     DOI: 10.1002/ajh.25432

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

Review 1.  Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review.

Authors:  Hirotaka Mori; Masahiko Fukatsu; Hiroshi Ohkawara; Yuka Oka; Yuki Kataoka; Shunsuke Taito; Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2021-08-30       Impact factor: 2.490

2.  Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients.

Authors:  Hanno M Witte; Nadine Hertel; Hartmut Merz; Heinz-Wolfram Bernd; Veronica Bernard; Stephanie Stölting; Nikolas von Bubnoff; Alfred C Feller; Niklas Gebauer
Journal:  Blood Cancer J       Date:  2020-05-29       Impact factor: 11.037

Review 3.  [Isolated plasmablastic lymphoma of nasal mucosa in an immunocompetent patient achieving complete remission after multimodal treatment: about an African patient and literature review].

Authors:  Rajaa Tissir; Hanan Rais; Ilyas Tazi
Journal:  Pan Afr Med J       Date:  2020-09-05

4.  Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.

Authors:  Hanno M Witte; Axel Künstner; Nadine Hertel; Heinz-Wolfram Bernd; Veronica Bernard; Stephanie Stölting; Hartmut Merz; Nikolas von Bubnoff; Hauke Busch; Alfred C Feller; Niklas Gebauer
Journal:  Blood Adv       Date:  2022-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.